Scarica l'app Stockscreener
7.305
2.36%
0.145
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$7.16
Aprire:
$7.16
Volume 24 ore:
572.51K
Relative Volume:
0.26
Capitalizzazione di mercato:
$764.53M
Reddito:
-
Utile/perdita netta:
$-258.08M
Rapporto P/E:
-2.6564
EPS:
-2.75
Flusso di cassa netto:
$-202.32M
1 W Prestazione:
+5.15%
1M Prestazione:
-3.44%
6M Prestazione:
-57.76%
1 anno Prestazione:
-66.46%
Intervallo 1D:
$7.0425
$7.3293
Intervallo di 1 settimana:
$6.945
$7.50
Portata 52W:
$4.55
$26.98
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
Nome
Rocket Pharmaceuticals Inc
Settore
Industria
Telefono
646-440-9100
Indirizzo
350 FIFTH AVENUE, NEW YORK, NY
Confronta RCKT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
7.315 | 764.53M | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.41 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.57 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
633.00 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
259.44 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
247.69 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-12 | Iniziato | BMO Capital Markets | Outperform |
| 2024-12-30 | Iniziato | Wedbush | Outperform |
| 2024-12-18 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-04-02 | Iniziato | Goldman | Neutral |
| 2023-10-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-02-01 | Iniziato | Morgan Stanley | Overweight |
| 2022-11-08 | Iniziato | Canaccord Genuity | Buy |
| 2022-11-01 | Iniziato | BTIG Research | Buy |
| 2022-07-08 | Iniziato | Raymond James | Outperform |
| 2021-10-20 | Ripresa | Cowen | Outperform |
| 2021-03-02 | Iniziato | Stifel | Buy |
| 2021-02-18 | Iniziato | Needham | Buy |
| 2020-12-16 | Iniziato | UBS | Buy |
| 2020-12-08 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-07-02 | Iniziato | JP Morgan | Overweight |
| 2020-06-25 | Ripresa | BofA/Merrill | Buy |
| 2020-06-01 | Ripresa | Oppenheimer | Outperform |
| 2019-11-06 | Iniziato | Chardan Capital Markets | Buy |
| 2019-09-26 | Iniziato | Piper Jaffray | Overweight |
| 2019-04-23 | Iniziato | Robert W. Baird | Outperform |
| 2019-03-15 | Iniziato | BofA/Merrill | Buy |
| 2019-02-05 | Iniziato | Oppenheimer | Outperform |
| 2018-09-13 | Iniziato | Ladenburg Thalmann | Buy |
| 2018-07-10 | Iniziato | William Blair | Outperform |
Mostra tutto
Rocket Pharmaceuticals Inc Borsa (RCKT) Ultime notizie
Rocket Pharmaceuticals Inc (RCKT)’s Market Momentum: Closing Strong at 7.16, Down -0.97 - DWinneX
Rocket Pharmaceuticals Inc (RCKT) stock analysis: A simple moving average approach - uspostnews.com
Rocket Pharmaceuticals Inc [RCKT] Insider Activity: An Update for Investors - knoxdaily.com
Is Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Stock Worth Investing In for High Returns? - Marketing Sentinel
Rocket Pharmaceuticals appoints new board member - MSN
RCKT stock touches 52-week low at $10.11 amid market challenges - MSN
RCKT stock touches 52-week low at $9.76 amid market challenges - MSN
Rocket Pharmaceuticals Inc (NASDAQ:RCKT) Could Actually Go To 39 In 12 Months - Marketing Sentinel
Understanding the Risks of Investing in Rocket Pharmaceuticals Inc (RCKT) - knoxdaily.com
Financial Metrics Exploration: Understanding Rocket Pharmaceuticals Inc (RCKT) Through Ratios - DWinneX
The Future of Rocket Pharmaceuticals Inc: Analyzing RCKT - investchronicle.com
Rocket Pharmaceuticals Inc [RCKT] Revenue clocked in at $0.00 million, down -42.96% YTD: What’s Next? - dbtnews.com
Our Attention Has Been Attracted to Rocket Pharmaceuticals Inc (NASDAQ:RCKT) - uspostnews.com
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Sold by Alliancebernstein L.P. - Defense World
Geode Capital Management LLC Increases Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
(RCKT) Trading Report - news.stocktradersdaily.com
JPMorgan Chase & Co. Sells 41,024 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
3 Stocks Insiders Are Buying Rapidly Amid Market Volatility - Investing.com
Is Rocket Pharmaceuticals (NASDAQ:RCKT) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Countdown To Approval: Rocket Pharma's Gene Therapy For Rare Disease Awaits FDA Decision - RTTNews
Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap Up After Insider Buying Activity - Defense World
Rocket Pharmaceuticals CEO buys $101.6K in common stock - MSN
Rocket Pharmaceuticals CEO Gaurav Shah acquires $101,600 in stock By Investing.com - Investing.com India
Rocket Pharmaceuticals CEO Gaurav Shah acquires $101,600 in stock - Investing.com Australia
If You Don’t Buy Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Now, You’ll Kick Yourself Later - stocksregister.com
Raymond James Financial Inc. Makes New $285,000 Investment in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharmaceuticals (NASDAQ:RCKT) Earns Buy Rating from Needham & Company LLC - Defense World
Rocket Pharmaceuticals executive Kinnari Patel buys $99,165 in stock By Investing.com - Investing.com South Africa
Rocket Pharmaceuticals executive Kinnari Patel buys $99,165 in stock - Investing.com
Rocket Pharma Out Of Orbit, But Ready For Re-Launch (NASDAQ:RCKT) - Seeking Alpha
The Escalator: Rocket Pharmaceuticals, Zenas BioPharma, Angelini Ventures - Medical Marketing and Media
Corebridge Financial Inc. Sells 2,469 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Vanguard Group Inc. Purchases 1,040,655 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharmaceuticals (RCKT): Among Stocks Under $10 that Will Triple - Insider Monkey
KLP Kapitalforvaltning AS Buys Shares of 15,300 Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharmaceuticals CFO sells $39,646 in stock By Investing.com - Investing.com India
Rocket Pharmaceuticals CFO sells $39,646 in stock - Investing.com
Rocket Pharmaceuticals CFO Sells Shares to Cover Tax Obligations - TradingView
10 Stocks Under $10 that Will Triple - Insider Monkey
BMO maintains Rocket Pharmaceuticals Outperform rating By Investing.com - Investing.com UK
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
Rocket Pharmaceuticals appoints new Chief Officer By Investing.com - Investing.com Canada
Rocket Pharmaceuticals appoints new Chief Officer - Investing.com Australia
Rocket Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference - BioSpace
Genetic Therapy Breakthroughs: Rocket Pharma CEO Set to Reveal Strategic Updates at Major Healthcare Conference - Stock Titan
Thrivent Financial for Lutherans Sells 21,731 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
RCKT stock plunges to 52-week low, hitting $5.68 - Investing.com
Is Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) the Best US Stock Under $10 to Buy Right Now? - MSN
Where are the Opportunities in (RCKT) - news.stocktradersdaily.com
Teacher Retirement System of Texas Raises Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - Defense World
Rocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 1-Year LowHere's Why - MarketBeat
Rocket Pharmaceuticals Inc Azioni (RCKT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.36%
0.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):